Wuhan Keqian Biology Co.,Ltd (SHA:688526)

Market Cap	7.43B +18.0%
Revenue (ttm)	950.29M +0.9%
Net Income	415.60M +8.7%
EPS	0.90 +9.8%
Shares Out	463.92M
PE Ratio	17.80
Forward PE	14.87
Dividend	0.43 (2.76%)
Ex-Dividend Date	Jun 16, 2025

Volume	2,145,180
Average Volume	2,594,453
Open	15.60
Previous Close	15.59
Day's Range	15.55 - 16.04
52-Week Range	14.39 - 20.39
Beta	0.54
RSI	46.35
Earnings Date	Apr 8, 2026

About SHA:688526

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. The company offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 922
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688526

Financial Performance

In 2025, SHA:688526's revenue was 950.29 million, an increase of 0.89% compared to the previous year's 941.92 million. Earnings were 415.60 million, an increase of 8.70%.